Intravesical mitozantrone in recurrent superficial bladder cancer.
Newling
D W
DW
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D008942:Mitoxantrone / Q000008:administration & dosage*; D009364:Neoplasm Recurrence, Local; D012660:Semantics; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control*
D000970:Antineoplastic Agents; D008942:Mitoxantrone